Prograf and Yonsa drug interactions - a phase IV clinical study of FDA data
Summary:
We study 42,500 people who take Prograf (tacrolimus) and Yonsa (abiraterone acetate). There is no drug interaction reported.
The study analyzes what interactions people have when they take Prograf and Yonsa. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Prograf?
Prograf has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 42,230 Prograf users. Check the latest studies of Prograf.
What is Yonsa?
Yonsa has active ingredients of abiraterone acetate. eHealthMe is studying from 270 Yonsa users. Check the latest studies of Yonsa.
No report is found.
Do you take Prograf and Yonsa?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
How the study uses the data?
The study uses data from the FDA. It is based on tacrolimus and abiraterone acetate (the active ingredients of Prograf and Yonsa, respectively), and Prograf and Yonsa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Aloxi and Ceftriaxone Sodium - 7 seconds ago
- Drug interactions of Levothyroxine Sodium and Apremilast - 26 seconds ago
- Could Unisom cause Neck Pain? - 38 seconds ago
- Drug interactions of Bactrim and Cefepime Hydrochloride - 44 seconds ago
- Drug interactions of Valacyclovir and Ampyra - 50 seconds ago
- Drug interactions of Estrace and Methenamine Hippurate - 55 seconds ago
- Alopecia Areata and Depression Aggravated - 56 seconds ago
- Drug interactions of Ventolin and Furosemide - a minute ago
- Drug interactions of Ozempic and Vancomycin - a minute ago
- Drug interactions of Jakafi and Orenitram - a minute ago